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Radiofrequency Field Exposure and Cancer:
What Dothe laboratory Studies Suggest?
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Significant concern has been raised about possible health effects from exposure to
radiofrequency (RF) electromagnetic fields, especially after the rapid introduction of mobile
telecommunications systems. Parents are especially concerned with the possibility that children
might develop cancer after exposure to the RF emissions from mobile telephone base stations
erected in or near schools. These questions have followed scientific reports suggesting that
residence near high voltage power lines may to be associated with an increased childhood
leukemia risk. Epidemiologic studies have been plagued by poor RF exposure assessment and
differences in methodology. There are no high-quality epidemiologic studies that can be used to
evaluate health risks from RF exposure. Laboratory studies in this area have been somewhat
confusing. Some animal studies suggest that RF fields accelerate the development of sarcoma
colonies in the lung, mammary tumors, skin tumors, hepatomas, and sarcomas. A substantial
RF-induced increase in lymphoma incidence in transgenic mice exposed for up to 18 months has
also been reported. In contrast, other studies have not found carcinogenic effects. These
conflicting results indicate the need for more well-conducted studies on laboratory animals,
supplemented with high-quality in vitro studies to identify effects that need further research in
vivo, and to characterize any acting mechanisms, especially at low RF field levels. This paper
provides a review of the laboratory studies and indicates what conclusions about RF-induced
cancer can be drawn. Environ Health Perspect 105(Suppl 6):1565-1568 (1997)
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Introduction
Radiofrequency (RF) fields are part ofthe
electromagnetic spectrum and have many
ofthe same properties as infrared radiation
(heat), except that RF fields have a lower
frequency. Electromagnetic fields are com-
posed ofelectric and magnetic waves, and
depending on the wavelength of the RF
field and distance from the source, mea-
surement ofboth the electric and magnetic
fields may be needed to properly character-
ize the RF source. RF fields have frequen-
cies between 300 Hz and 300 GHz (1).
Microwaves (300 MHz-300 GHz) are a
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subset of the RF spectrum and can be
called either RF or microwaves.
Electromagnetic fields ofextremely high
frequencies (i.e., high energy), such as
X-rays, are able to break molecular bonds in
cells to produce ionization (positively and
negatively charged molecules). The radiant
energycomponentofafieldneeded to break
the weakest macromolecular bond (hydro-
gen bond) is approximately 0.1 eV; a single
covalent bond is 3.6 eV (2). RF fields at fre-
quencies between 300 MHz and 300 GHz
have radiant energies between 1.24 and
1240 eV-hundreds oftimes less energy
than is needed to break molecular bonds
and cause ionization. This is why RF fields
arecalled nonionizingradiation (NIR).
The intensity (or power density) ofRF
fields is measured in watts per square meter
(W/m2) or in microwatts per square meter
(W/m2) for very weak fields. The units and
symbols used are as follows: 1 hertz (Hz)=1
cycle per second; 1 megahertz (MHz) = 1
million Hz; and 1 gigahertz (GHz)= 1 thou-
sand MHz. 1 W/m2= 1,000,000 W/m2.
The specific absorption rate (SAR) is a mea-
sure ofthe rate of RF energy absorption
within tissue. The unit for SAR is watts per
kilogram (W/kg).
Reviews ofthe epidemiologic studies on
both occupational and general public RF
exposure have concluded that there is no
consistent evidence ofa carcinogenic haz-
ard (1,3-6). Inconsistencies among recent
studies have not shed any further light
(7-13). Overall, epidemiologic studies suf-
fer from inadequate assessment ofexposure
and confounding, and poor methodology
(5,14). Further epidemiologic studies are
needed, particularly to investigate popula-
tions ofmobile telephone users, among
which accurate RF exposure assessments
are nowpossible.
Results from current laboratory investi-
gations ofbiological effects ofexposure to
RF fields are consistent with responses to
induced heating, which causes a rise in tis-
sue or body temperature ofgreater than
1 °C (1). Most studies have examined end
points other than cancer, such as physio-
logic and thermoregulatory responses,
effects on behavior, induction oflens opac-
ities (cataracts), and adverse reproductive
outcomes following acute exposure to rela-
tively high levels of RF fields. Very few
studies are relevant to the evaluation of
low-level RF exposure and its effects on the
development ofcancer in humans.
This paper reviews the published
laboratory studies, both in vitro and in vivo,
that relate to cancer causation from low-level
RF field exposure in various biological sys-
tems and draws conclusions about possible
cancerrisk.
Laboratory Studies
The laboratory studies dexcribed in this
paper fall into two categories:
a) In vitro studies are conducted on
isolated components ofbiological systems
such as solutions ofmolecules (e.g., DNA),
cultures ofcells, or pieces oftissue. These
studies are important for determining
possible mechanisms by which RF fields
interact with biological systems and for
identifying appropriate end points and
exposure conditions to be tested in whole
animals. It is important to determine
mechanisms of interaction in order to
understand how RF fields act at the mole-
cular or cellular level and extrapolate in
vitro results to the in vivo level. Studying
simple systems allows interactions to be
detected that may be masked in the com-
plexity ofinteractions that occur normally
within the whole animal. Thus, biological
effects found in vitro must still be tested
in vivo.
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b) In vivo studies are conducted on
complete biological systems such as labora-
tory animals. The great advantage ofthese
studies is that they are conducted under
laboratory conditions with environmental
and exposure parameters that can be care-
fully controlled. The only difference
between exposed and unexposed animals
should be their actual exposure to RF fields.
Because experiments cannot normally be
conducted on humans, animal studies are
very useful for making health risk assess-
ments. However, the results of animal
studies are only applicable to humans ifthe
observed effects occur in various types of
animals; one animal model may be
extremely sensitive to a particular end point
and display reactions not observed in
humans (15,16).
Cancer
In considering the laboratory evidence,
each component in the carcinogenesis
process is addressed: initiation, promotion,
and progression.
InitiationStudies
Most in vitro studies have reported a lack
of RF-induced DNA damage [for
reviews, see (1,5,6,14,17)]. A lack of
effect from RF exposure has also been
reported on mutation frequency in yeast
(18,19) on mouse leukemia cells (20), or
on chromosome aberration frequency in
human lymphocytes (21,22).
However, two rodent studies suggest
that RF fields may affect DNA directly.
When mice were exposed to 2.45-GHz
fields at an SAR of 1.18 W/kg for 2 hr/day
for 120, 150, and 200 days, structural
genomic rearrangements were found in
brain and testes cells (23). Lai and Singh
(24,25) reported that rats exposed to
pulsed (2 sec pulses, 500 pulses/sec) or
continuous wave (CW) 2.45-GHz fields
with SARs of 0.6 or 1.2 W/kg for 2 hr
increased the number of single and
double-strand breaks in brain cell DNA
when assayed 4 hr after RF exposure. Lai
and Singh (26) also reported that treat-
ment of rats immediately before or after
exposure with either melatonin (1 mg/kg)
or PBN (N-tert-butlylphenylnitrone, 100
mg/kg) blocks the formation of DNA
breaks by RF fields. These experiments
challenge the belief that RF fields are
unable to break molecular bonds. Epi-
genetic events may be involved; therefore,
it is important to replicate these studies
and determine dose-response relation-
ships before they can be used in health
risk assessments, especially given the
weight of evidence suggesting that RF
fields are not genotoxic.
Promotion andProgression Studies
Studies have tested the possibility that RF
fields may influence tumor promotion
through increases in the rate ofcell prolifer-
ation, or via effects mediated through
changes in proliferative signaling pathways,
leading to enhanced transcription and DNA
synthesis, with conflicting results (27,28).
Ion fluxes through the cell membrane con-
stitute important signaling mechanisms. A
number of reports suggest that RF fields
may be capable ofaffecting ion fluxes via
effects on ion pumps such as Na+K+-ATPase
in human red blood cells exposed to RF and
microwave radiation (29,30).
Athermal effects on gross transcription,
as measured by incorporation of the spe-
cific RNA precursor 3H-uridine, have been
reported following the exposure ofglioma
cells to CW RF and microwave radiation
(31). Similar effects on cellular prolifera-
tion, assayed as the incorporation of the
specific DNA precursor 3H-thymidine,
were also reported following exposure of
human lymphocytes (32) or glioma cells
(31). Both transcription and proliferation
were elevated at an SAR of 25 W/kg but
appeared to be unchanged or even
depressed at higher SARs. RF exposure has
also been reported to induce activity ofthe
enzyme ornithine decarboxylase (ODC),
levels ofwhich are often elevated duringcell
growth and tumor promotion. The expo-
sure of mouse fibroblasts to amplitude-
modulated microwaves at an SAR of 3
W/kg increased ODC activity (33), but to
a much lower level than treatment with a
chemical promoter. It should be noted,
however, that changes in the level ofthis
enzyme are not necessarily indicative of
tumor promotion (34).
Assays of cell transformation are used
to detect changes consistent with tumori-
genesis but do not provide information on
the nature ofthe damage giving rise to the
change. An increased rate of in vitro trans-
formation has been reported (35-37) in a
chromosomally abnormal cell line.
Enhanced transformation rates were found
in C3H10TI/2 cells exposed to combined
amplitude-modulated microwaves (4.4
W/kg) and X-rays followed by treatment
with the chemical promoter 12-O-tetrade-
canoylphorbol-13-acetate (TPA), com-
pared with cells exposed only to X-rays
and TPA (35). Similar levels ofenhanced
transformation rates were found after
exposure to microwaves and/or X-rays
(1.5 Gy), followed by treatment with the
promoter (36). However, there are incon-
sistencies between these two studies. In the
first study, microwave exposure resulted in
a 50% reduction in plating efficiency,
whereas in the second study no such effect
was observed. Further, although the data
from the second study were consistent
with an additive effect ofmicrowaves and
X-rays when followed by TPA treatment,
unlike the first study, this effect was not
statistically significant.
Balcer-Kubiczek and Harrison (37)
also reported that exposure to microwaves
at SARs between 0.1 and 4.4 W/kg, fol-
lowed by TPA treatment, resulted in a
dose-dependent induction of transforma-
tion. In addition, microwave exposure
slightly enhanced the effects ofX-irradia-
tion and TPA on transformation rate.
These studies are important, but their rela-
tionship to carcinogenesis in vivo is unclear.
C3HIOT1/2 cells are highly abnormal chro-
mosomally and their response to prolifera-
tive stimuli may be atypical. In addition,
transformation studies tend to be susceptible
to a variety of experimental confounding
factors (4).
Szmigielski et al. (38) and Szudzinski et
al. (39) report that chronic exposure of
mice to RF (2.45 GHz, 2-3 or 6-8 W/kg,
2 hr/day, 6 days/week for up to 12 months;
40 or 100 animals/group) accelerated the
development of sarcoma colonies in the
lung after subcutaneous injection of sar-
coma cells; mammary tumors in mice hav-
ing a normally high incidence of these
tumors; and skin tumors that were chemi-
cally induced in mice by painting the skin
with the carcinogen 3,4-benzo[a]pyrene.
Szmigielski et al. (40) also reported that
exposure to RF fields (2.45 GHz CW, 4-5
W/kg, 2 hr/day, 5-6 days/week for a few
months; 40 animals/group) increased the
number ofchemically induced hepatomas
and sarcomas and increased the number of
skin tumors in mice given a subcarcino-
genic dose ofbenzo[a]pyrene. The authors
suggested that the acceleration of tumor
development may have resulted from a
direct effect on immunocompetent cells.
However, the possibility that heating and
cage stress mayhave influenced the progress
ofthese tumors cannot be dismissed.
In contrast to the reports ofSzmigielski
et al. and Szudzinski and co-workers,
Salford et al. (41) report no effect on the
progression oftumors cells injected into rat
brain after exposure to continuous or
pulsed 915-MHz RF fields (CW exposure,
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1 W/pulse, 1.67 W/kg; 0.41 W/kg for 217
Hz modulation, pulse width 0.52 msec, 2
W/pulse; 62 animals/group). Santini et al.
(42) found that the progression ofsubcuta-
neously implanted melanoma cells in mice
was unaffected by daily exposure to pulsed
or CW exposure to RF fields (2.45 GHz
CW and pulsed, 10 W/m2, 1.2 W/kg, 2.5
hr/day, 6 days/week, for the lifetime ofthe
animal). Also, Wu et al. (43) report no
effect of RF exposure (2.45 GHz exposed
3 hr/day, 6 days/week for 5 months; aver-
age SAR 10-12 W/kg) on chemically
induced colon cancer in mice. Rotkovska
et al. (44) found that exposure ofmice to
low-level RF fields from a police radar (34
GHz) did not affect biological parameters
that could initiate any pathologic process.
One hundred rats were exposed to RF
fields (2.45 GHz, 800 pulses/sec, 10-sec
pulse width, average SAR 0.15-0.4 W/kg,
depending on the size ofthe rat, 21.5 hr/day
for 25 months) and compared with 100
sham-exposed controls (45). Tests ofmore
than 155 parameters were negative for
effects on general health, longevity, cause of
death, or lesions associated with aging or
benign neoplasms. The authors reported
that no single type ofmalignant tumor was
enhanced byexposure. The incidence ofpri-
mary malignancies in the exposed group was
significantly higher than in controls, butwas
similar to the levels ofprimary malignancies
reported elsewhere in this strain ofrat.
Repacholi et al. (46) report a 2.4-fold
increase in the incidence oflymphomas in
Ef4-piml transgenic mice exposed for up to
18 months to 900-MHz fields pulsed at 217
Hz with pulse widths of0.6 sec. The time
to lymphoma development was also shorter
in the RF-exposed animals. This is the first
and only study using transgenic animals
exposed to RF fields. Transgenic animals
provide a very sensitive model for the end
point to be tested. If the study had pro-
duced no RF-induced increase in lym-
phoma, it would have provided substantial
evidence that RF fields do not influence
lymphomagenesis. Fewer transgenic than
normal animals are needed to detect a given
effect promoted by RF fields. It should be
remembered that the mice were genetically
engineered for a predisposition to lym-
phoma by insertion ofextrapiml oncogenes
into the DNA. Thus the relevance ofresults
found in a very sensitive animal model to
possible carcinogenesis in humans still needs
to be determined. However, since the only
difference between transgenic and normal
mice is the insertion ofthe oncogene, this
study could provide an in vivo model for
determining how RF fields interact at the
molecular level. Further research is needed
to replicate and extend the results to deter-
mine ifthere is a dose-response relationship
and to determine the applicability ofresults
found in transgenic mice to possible effects
in humans.
Overall, the evidence suggests that RF
exposure is not mutagenic and is therefore
unlikely to initiate cancers. The evidence
for a co-carcinogenic effect or an effect on
tumor promotion or progression is sugges-
tive but not substantive. The few studies
conducted to date are sufficiently indicative
to merit further investigation.
Amltde-modulte
RaJofiquesyEffect
Several research groups have noted effects
from exposure to very low levels ofampli-
tude-modulated RF fields. Such exposure,
at levels too low to involve heating, report-
edly altered electrical activity of the brain
in cats and rabbits; activity ofthe enzyme
ODC, levels ofwhich may be elevated dur-
ing tumor promotion; and calcium ion
mobility in brain tissue in vivo and in vitro
(1,34). Effective SARs in vitro were less
than 0.01 W/kg, occurring within modula-
tion frequency windows (usually between 1
and 100 Hz,) and sometimes within power
density windows. These changes in calcium
ion mobility have not been easy to corrob-
orate and challenge the conventional
assumption that the likelihood or severity
ofan effect increases as a function ofdose.
Further, they are not sufficiently well
established nor are their implications for
human health understood (14).
Conclusions
Reviewers evaluating possible links
between RF exposure and excess risk of
cancer have concluded that there is no
clear evidence for such a link (1,3-6,14).
The United Kingdom NRPB Advisory
Group on Non-ionising Radiation con-
cluded that there is no firm quantitative
evidence of a carcinogenic hazard from
electromagnetic field exposures for the
general public and workers in the electri-
cal, electronics, and telecommunications
industries (4). Studies published since this
review was completed have not shed any
further light on the possibility that RF
exposure poses a carcinogenic risk. After a
detailed review of the scientific literature,
the International Commision on Non-
ionizing Radiation Protection (ICNIRP)
(5) concluded that "there is no substantive
evidence that adverse health effects, includ-
ing cancer, can occur in people exposed to
levels at or below the limits on whole body
average SAR recommended by INIRC
(47), or, at or below the ICNIRP limits
for localised SAR...."
Few studies have been conducted that
specifically address the issue of cancer
and RF exposure. More multidisciplinary
focused studies are needed to address this.
This is one ofthe goals ofthe International
Electromagnetic Fields Project (48). The
first scientific review meeting to reach
interim conclusions on health risk and
identify research needs, was held in
Munich in November 1996. The results
of this review will be available shortly
(14). The conclusion was that "although
hazards from exposure to high-level (ther-
mal) RF fields were established, no
known health hazards were associated
with exposure to RF sources emitting
fields too low to cause a significant tem-
perature rise in tissue. Biological effects
from low-level RF exposure were identi-
fied needing replication and further
study." High priority research needs were
epidemiology and animal carcinogenesis
studies and in vitro studies identifying
effects that can be tested in vivo.
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